Morton JI, Marquina C, Shaw JE, Liew D, et al. Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis. Diabetologia 2022 Nov 21. doi: 10.1007/s00125-022-05832.
PMID: 36404375